Jensen Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78M Sell
11,064
-80
-0.7% -$17.2K 0.07% 60
2026
Q1
$2.42M Hold
11,144
0.05% 61
2025
Q4
$2.55M Sell
11,144
-6,978
-39% -$1.59M 0.04% 65
2025
Q3
$4.2M Sell
18,122
-4,105
-18% -$836K 0.05% 54
2025
Q2
$4.13M Hold
22,227
0.05% 56
2025
Q1
$4.66M Hold
22,227
0.05% 53
2024
Q4
$3.95M Hold
22,227
0.04% 61
2024
Q3
$4.39M Hold
22,227
0.04% 63
2024
Q2
$3.81M Hold
22,227
0.03% 64
2024
Q1
$4.05M Sell
22,227
-10
-0% -$1.72K 0.03% 66
2023
Q4
$3.45M Hold
22,237
0.03% 70
2023
Q3
$3.31M Sell
22,237
-130
-0.6% -$19.1K 0.03% 69
2023
Q2
$3.01M Sell
22,367
-1,500
-6% -$220K 0.02% 72
2023
Q1
$3.77M Hold
23,867
0.03% 65
2022
Q4
$3.86M Sell
23,867
-90
-0.4% -$13.8K 0.03% 66
2022
Q3
$3.21M Hold
23,957
0.03% 68
2022
Q2
$3.67M Buy
23,957
+300
+1% +$45.8K 0.03% 63
2022
Q1
$3.83M Hold
23,657
0.03% 64
2021
Q4
$3.2M Sell
23,657
-500
-2% -$59.1K 0.02% 65
2021
Q3
$2.61M Sell
24,157
-100
-0.4% -$11.4K 0.02% 66
2021
Q2
$2.73M Hold
24,257
0.02% 63
2021
Q1
$2.63M Sell
24,257
-1,200
-5% -$128K 0.02% 59
2020
Q4
$2.73M Buy
25,457
+52
+0.2% +$5K 0.02% 51
2020
Q3
$2.23M Hold
25,405
0.02% 43
2020
Q2
$2.49M Hold
25,405
0.02% 38
2020
Q1
$1.94M Hold
25,405
0.02% 38
2019
Q4
$2.25M Hold
25,405
0.02% 39
2019
Q3
$1.92M Hold
25,405
0.02% 40
2019
Q2
$1.85M Sell
25,405
-200
-0.8% -$15.7K 0.02% 39
2019
Q1
$2.06M Sell
25,605
-1,600
-6% -$131K 0.02% 38
2018
Q4
$2.51M Sell
27,205
-130
-0.5% -$11.4K 0.04% 36
2018
Q3
$2.58M Hold
27,335
0.03% 35
2018
Q2
$2.53M Sell
27,335
-65
-0.2% -$6.35K 0.03% 35
2018
Q1
$2.59M Sell
27,400
-1,100
-4% -$121K 0.03% 35
2017
Q4
$2.76M Sell
28,500
-270
-0.9% -$25.4K 0.04% 35
2017
Q3
$2.56M Sell
28,770
-1,450
-5% -$110K 0.03% 35
2017
Q2
$2.19M Sell
30,220
-300
-1% -$20.2K 0.03% 34
2017
Q1
$1.99M Sell
30,520
-500
-2% -$31.4K 0.03% 34
2016
Q4
$1.94M Sell
31,020
-400
-1% -$24.4K 0.03% 34
2016
Q3
$1.98M Hold
31,420
0.03% 34
2016
Q2
$1.95M Hold
31,420
0.03% 34
2016
Q1
$1.79M Sell
31,420
-50
-0.2% -$2.79K 0.03% 34
2015
Q4
$1.86M Hold
31,470
0.03% 33
2015
Q3
$1.71M Sell
31,470
-2,600
-8% -$169K 0.03% 34
2015
Q2
$2.29M Hold
34,070
0.04% 33
2015
Q1
$1.99M Sell
34,070
-1,917
-5% -$116K 0.03% 34
2014
Q4
$2.35M Sell
35,987
-4,033
-10% -$254K 0.04% 32
2014
Q3
$2.31M Sell
40,020
-863
-2% -$47.9K 0.04% 31
2014
Q2
$2.31M Hold
40,883
0.03% 31
2014
Q1
$2.1M Sell
40,883
-800
-2% -$40.4K 0.03% 31
2013
Q4
$2.2M Sell
41,683
-397
-0.9% -$19.5K 0.03% 32
2013
Q3
$1.88M Sell
42,080
-1,561
-4% -$69.2K 0.03% 31
2013
Q2
$1.8M Buy
+43,641
New +$1.91M 0.03% 32

Other funds holding ABBV

Jensen Investment Management's ABBV Position: Q2 2026 in Review

Jensen Investment Management reduced its AbbVie (ABBV) stake by 0.72% in Q2 2026, selling an estimated $17.2K and leaving 11,064 shares worth $2.78M. The position accounts for 0.07% of the portfolio, ranked #60.

Jensen Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.66M in Q1 2025. 3,003 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jensen Investment Management held 11,064 shares of AbbVie worth $2.78M as of Q2 2026.
  • Jensen Investment Management sold 80 AbbVie shares in Q2 2026, an estimated $17.2K.
  • AbbVie made up 0.07% of Jensen Investment Management's portfolio in Q2 2026, its #60 holding.
  • Jensen Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Jensen Investment Management's AbbVie position peaked at $4.66M in Q1 2025.
  • 3,003 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jensen Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.